The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type - Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

被引:83
|
作者
Castano, EM
Prelli, F
Soto, C
Beavis, R
Matsubara, E
Shoji, M
Frangione, B
机构
[1] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016
[3] GUNMA UNIV,SCH MED,DEPT NEUROL,GUNMA 371,JAPAN
关键词
D O I
10.1074/jbc.271.50.32185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCEFWA-D), a genetic variant (E22Q) of amyloid beta (A beta) accumulates predominantly in the small vessels of leptomeninges and cerebral cortex, leading to fatal strokes in the fifth or sixth decade of life, A beta deposition in the neuropil occurs mainly in the form of preamyloid, Congo red negative deposits, while mature neuritic plaques and neurofibrillary tangles, hallmark lesions in Alzheimer's disease (AD), are characteristically absent, A recent hypothesis regarding the patho genesis of AD states that A beta extending to residues 42-43 (as opposed to shorter species) can seed amyloid formation and trigger the development of neuritic plaques followed by neuronal damage in AD. We characterized biochemically and immunohistochemically A beta from three cases of HCHWA-D to determine its length in vascular and parenchymal deposits, Mass spectrometry of formic acid-soluble amyloid, purified by size-exclusion gel chromatography, showed that A beta 1-40 and its carboxyl-terminal truncated derivatives were the predominant forms in leptomeningeal and cortical vessels, A beta 1-42 was a minor component in these amyloid extracts, Immunohistochemistry with antibodies S40 and S42, specific for A beta ending at Val-40 or Ala-42, respectively, were consistent with the biochemical data from vascular amyloid. In addition, parenchymal preamyloid lesions were specifically stained with S42 and were not labeled by S40, in agreement with the pattern reported for AD, Down's syndrome, and aged dogs, Our results suggest that in HCHWA-D the carboxyl-terminal A beta heterogeneity is due to limited proteolysis in vivo, Moreover, they suggest that A beta species ending at Ala-42 may not be critical for the seeding of amyloid formation and the development of AD-like neuritic changes.
引用
收藏
页码:32185 / 32191
页数:7
相关论文
共 50 条
  • [31] Effects of rosiglitazone treatment on serum amyloid-beta 1-40 and 1-42 in patients with early Alzheimer's disease
    Kulstad, J
    Green, PS
    Cook, DG
    Watson, GS
    Reger, M
    Cholerton, B
    Baker, LD
    Plymate, SR
    Asthana, S
    Fishel, M
    Kahn, SE
    Craft, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S354 - S355
  • [32] Innate immunity and amyloid-beta clearance in Alzheimer's disease
    Fiala, M
    Chiappelli, F
    Graves, MC
    NEUROBIOLOGY OF AGING, 2004, 25 : S533 - S533
  • [33] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
    Evan Dorey
    Nina Chang
    Qing Yan Liu
    Ze Yang
    Wandong Zhang
    Neuroscience Bulletin, 2014, 30 : 317 - 330
  • [34] Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
    Norelle C. Wildburger
    Thomas J. Esparza
    Richard D. LeDuc
    Ryan T. Fellers
    Paul M. Thomas
    Nigel J. Cairns
    Neil L. Kelleher
    Randall J. Bateman
    David L. Brody
    Scientific Reports, 7
  • [35] Amyloid-beta and tau protein beyond Alzheimer's disease
    Abyadeh, Morteza
    Gupta, Vivek
    Paulo, Joao A.
    Mahmoudabad, Arezoo Gohari
    Shadfar, Sina
    Mirshahvaladi, Shahab
    Gupta, Veer
    Nguyen, Christine T. O.
    Finkelstein, David I.
    You, Yuyi
    Haynes, Paul A.
    Salekdeh, Ghasem H.
    Graham, Stuart L.
    Mirzaei, Mehdi
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1262 - 1276
  • [36] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
    Dorey, Evan
    Chang, Nina
    Liu, Qing Yan
    Yang, Ze
    Zhang, Wandong
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 317 - 330
  • [37] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
    Evan Dorey
    Nina Chang
    Qing Yan Liu
    Ze Yang
    Wandong Zhang
    Neuroscience Bulletin, 2014, 30 (02) : 317 - 330
  • [38] Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease
    He, Chuan
    Huang, Zhong-sheng
    Yu, Chao-chao
    Wang, Hai-hua
    Zhou, Hua
    Kong, Li-hong
    CURRENT MEDICAL SCIENCE, 2020, 40 (06): : 1022 - 1030
  • [39] PET amyloid-beta imaging in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Benzinger, Tammie L. S.
    Morris, John C.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
  • [40] Impaired hepatic amyloid-beta degradation in Alzheimer's disease
    Maarouf, Chera L.
    Walker, Jessica E.
    Sue, Lucia I.
    Dugger, Brittany N.
    Beach, Thomas G.
    Serrano, Geidy E.
    PLOS ONE, 2018, 13 (09):